Our research aims to accelerate drug discovery using computational models. By combining detailed modeling of protein-ligand complexes at the atomic scale with high-throughput experimental validation, we drive the discovery and development of novel therapeutics.
DNA repair and replication
Inhibitors that block DNA repair and replication mechanisms to treat cancer.
Broad-spectrum antivirals
Inhibitors that block the replication cycle in flaviviruses.
Antibiotics targeting ESKAPEs
Antibacterials that kill Gram-negatives like P. aeruginosa and K. pneumoniae.